header shadow

Publications (Since 2002)

  1. Jones DE, MR Ackermann, W Ulrike, CA Hunter, P Scott. 2002. An early enhanced Th1 response after L. amazonensis infection of C57BL/6 IL-10 KO mice does not lead to the resolution of the infection. Infection and Immunity 70:2151-2158.
  2. Waters R, J. Miller, MV Palmer, JR Stabel, DE Jones, KA Koistinen, EM Steadham, MJ Hamilton, WC Davis, JP Bannantine. 2003. Early induction of a humoral and cellular immune response during experimental Mycobacterium avium subsp. paratuberculosis infection of calves. Infection and Immunity 71:5130-5138
  3. Vanloubbeeck Y, J Hostetter and DE Jones. 2003. The Biology of Dendritic Cells and their Potential Use in Veterinary Medicine. Animal Health Research Reviews 4(2); 131-142.
  4. Vanloubbeeck Y. and DE Jones. 2004. The Immunology of Leishmania Infection and the Implications for Vaccine Development. Annals of the New York Academy of Science. Proceedings of the Society for Tropical Veterinary Medicine; 1026; 267-272.
  5. Vanloubbeeck Y and DE Jones. 2004. Infection of C3HeB/FeJ mice with Leishmania major protects against subsequent challenge with Leishmania amazonensis. The American Journal of Tropical Medicine and Hygiene; 71(4); 407-411.
  6. Vanloubbeeck Y, AE Ramer, Jie, F. and DE Jones. 2004. CD4+ Th1 cells induced by a dendritic cell-based immunotherapy in mice chronically infected with L. amazonensis do not promote healing. Infection and Immunity ; 72, 4455-4463.
  7. Simutis, F.J., N.F. Cheville and DE Jones. 2005. Antigen-specific T cell responses and subcutaneous granuloma development during experimental sensitization of bovine calves with Mycobacterium avium subsp. paratuberculosis. American Journal of Veterinary Research; 66(3) 474-482.
  8. Vanloubbeeck, Y., M. R. Ackermann and D. E. Jones 2005. Late Cutaneous Metastases in C3H SCID Mice Infected with Leishmania amazonensis. Journal of Parasitology 91(1); 226-228.
  9. Mukbel, R. M., Petersen C. A., and Jones D. E. (2006) “Soluble factors from Leishmania major-specific CD4+ T cells and B cells limit L. amazonensis amastigote survival within infected macrophages.” Microbes Infect., Vol 8(9-10), 2547-2555. (PMID: 16934514- free online).
  10. Ramer, A.E., Y. Vanloubbeeck and D.E. Jones. 2006. Antigen-responsive CD4+ T cells from C3H mice chronically infected with Leishmania amazonensis are impaired in their transition to effector phenotype. Infection and Immunity; 74 (3); 1547-1554.
  11. Coetzee, J.F., Apley, M.D., Kocan, K.M. and Jones, D.E. 2006. Flow cytometric evaluation of selected antimicrobial efficacy for clearance of Anaplasma marginale in short-term erythrocyte cultures. Journal of Veterinary Pharmacology and Therapeutics; 29; 173-183.
  12. Dancik, G.M., Jones, D.E., and Dorman, K.S, 2006. An agent-based model for Leishmania infection. Interjournal of Complex Systems, 1853.
  13. Simutis, F.J., Jones, D.E. and Hostetter, J. 2007. Failure of antigen-stimulated gamma-delta T cells and CD4+ T cells from sensitized cattle to upregulate nitric oxide and mycobactericidal activity of autologous Mycobacterium avium subsp. paratuberculosis-infected macrophages. Veterinary Immunology and Immunopathology. March 15; 116 (1-2): 1-12.
  14. Mukbel R.M., Patten C., Ghosh, M, Gibson-Corley, K, Petersen C. and Jones D.E. (2007) “Macrophage killing of Leishmania amazonensis amastigotes requires both nitric oxide and superoxide.” Am. J. Trop. Med. Hygiene, Vol 76(4), 669-675. (PMID: 17426168- Free online).
  15. Fisch, S., Grey, S, Heymans, S, Wang, B, Haldar, S, Pfister, O, Cui, L, Kumar, A, Lin, Z, Sen-Banerjee, S, Das, H, Petersen C.A., Mende, U, Burleigh, B.A., Zhu, Y, Pinto, Y, Liao, R, and Jain M.K. (2007) “The Kruppel-like factor KLF15 is a novel regulator of cardiomyocyte hypertrophy.” Proc. Nat. Acad. Sci., Vol 104, 7074-7079. (PMC1855421).
  16. Gibson-Corley, K. N., Hostetter, J.M., Hostetter, S.J., Mullin, K., Ramer-Tait, A.E., Boggiatto, M.P., Petersen, C.A. (2008) “Disseminated Leishmania infantum Infection in Two Sibling Foxhound Dogs from Potential Vertical Transmission.” Can. Vet. J., Vol. 49, 1005-1008. (PMC2553493).
  17. Su, B., Wen, Z., Dorman, K., Jones, D.E. 2008 Mathematical modeling of Immune Response in Tissues. Computational and Mathematical Methods in Medicine. March, 10(1): 9-38.
  18. Wagner, S., Apley, M. and Jones, D.E. Endotoxic Mastitis in Cows Causes Sloughing of Epithelial Cells into the Milk. American Journal of Veterinary Research. 2009; June, 70(6): 796-799.
  19. Sponseller, B.A., de Macedo, M.M., Clark, S.K., Gallup, J.M., Jones, D.E., Activation of peripheral blood monocytes results in more robust production of IL-10 in neonatal foals compared to adult horses. Vet Immunology and Immunopathology. 2009. Jan 15;127(1-2):167-73.
  20. Johann F. Coetzee, Katherine M. Kocan, Judith A. Stasko, James J. Higgins, Michael D. Apley, and Douglas E. Jones; (2009) Ultrastructural and fluorochromatic changes in Anaplasma marginale exposed to oxytetracycline, imidocarb and enrofloxacin in short-term erythrocyte cultures. Veterinary Microbiology. Apr 14;71(3):361-5.
  21. Opriessnig, T., Patterson, A.R., Jones, D.E., Juhan, N.M., Meng, X-J., Halbur, P.G. (2009) Limited susceptibility of three different mouse (Mus musculus) lines to Porcine circovirus-2 infection and associated lesions. Canadian Journal of Veterinary Research. Apr;73(2):81-86.
  22. Boggiatto, M. P., Ghosh, M., Gibson-Corley, K. N., Jie, F., Ramer-Tait, A. E., Jones, D. E., Petersen, C. A. (2009) “Altered dendritic cell phenotype in response to L. amazonensis is mediated by MAP kinase ERK.” Am. J. Path., Vol. 174(5), 1818-1826. (PMC2671270).
  23. Petersen, C.A. (2009) “New means of Canine Leishmaniasis transmission in North America; the possibility of transmission to humans still unknown.” Interdisc. Perspect. Infect. Dis., Article ID 802712, 5 pages. (doi:10.1155/2009/802712). (PMC2695953).
  24. Petersen, C.A. (2009) “Leishmaniasis: An Emerging Disease Found in Companion Animals in the United States.” Top. Comp. An. Med., Nov; Vol. 24(4),182-8. (PMC2805016 [Available on 2010/11/1]).
  25. Petersen, C.A., Barr, S. C., (2009) “Canine Leishmaniasis in North America: Emerging or Newly Recognized?” In: Vet Clin. of N. Am.; Small An. Pract., Elsevier publishing, edited by Lindsey, D and Zajac, A, Nov; 39(6):1065-74, vi. (PMC2824922 [Available on 2010/11/1]).
  26. Boggiatto, M.P., Ramer-Tait, A.E., Gallup, J., Gibson-Corley, K.N., Metz, K., Kramer, E.E., Hostetter, J.M., Jones, D.E., Petersen, C.A. (2010) “Immunologic indicators of clinical progression during canine Leishmania infantum infection.” Clin. Vacc. Immunol., Vol. 17(2), 267-73. (PMC2815526).
  27. Gibson-Corley K.N., Boggiatto P.M., Petersen C.A., Jones D.E. (2010) Co-infection with Leishmania major and Leishmania amazonensis in Two Murine Models; a role for B cells in the Cell-Mediated Immune Response. Inter.J. Parasit., Vol. 40,157-161. (PMC2814795 [Available on 2011/2/1])
  28. E. Song, A. Osanya, P. Boggiatto, C. Petersen and N. Pohl. (2010) “Synthesis of multivalent Leishmania-associated capping carbohydrates and evaluation of structure-dependent immune responses.” Journal of the American Chemical Society, Vol. 132 (33): 11428-30. (PMC Journal- in process)
  29. Dancik, G.M., Jones, D.E., Dorman, K.S., Parameter estimation and sensitivity analysis in an agent-based model of Leishmania major infection. 2010. J. Theo Bio. Feb 7; (262) 3:398-412.
  30. Amanda E. Ramer-Tait, Christine A. Petersen, Douglas E. Jones (2011) IL-2 limits IL-12 enhanced lymphocyte proliferation during Leishmania amazonensis infection. Cellular Immunology (In Press).